aspartic acid has been researched along with Kidney Failure, Chronic in 17 studies
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
"Cerebral metabolism in chronic renal failure (CRF) patients has not been fully evaluated." | 1.33 | Positive correlations between cerebral choline and renal dysfunction in chronic renal failure. ( Hattori, N; Inenaga, T; Inoue, N; Kawano, Y; Kohno, S; Nakahama, H; Nakamura, S; Sasaki, O; Sawada, T, 2006) |
" Uremic toxins were also incubated with purified human albumin, and dose-response experiments with the two most toxic agents in terms of protein damage (guanidine and guanidinopropionic acid) were carried out." | 1.32 | Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences. ( D'Aniello, A; De Santo, NG; Galletti, P; Ingrosso, D; Lombardi, C; Perna, AF; Satta, E, 2004) |
"ADPKD is associated with altered endothelial-dependent vasodilation and decreased vascular production of nitric oxide (NO)." | 1.31 | Modifier effect of ENOS in autosomal dominant polycystic kidney disease. ( Balligand, JL; Chauveau, D; Davila, S; Devuyst, O; El-Khattabi, O; Feron, O; Horie, S; Lens, XM; Messiaen, T; Mourad, M; Persu, A; Pirson, Y; Robino, C; Stoenoiu, MS; Wattiez, R, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Wang, J | 1 |
Zhou, T | 1 |
Liu, J | 2 |
Shangguan, J | 1 |
Liu, X | 1 |
Li, Z | 1 |
Zhou, X | 1 |
Ren, Y | 1 |
Wang, C | 1 |
Ma, X | 1 |
Zhang, Y | 1 |
Ma, S | 1 |
Li, P | 1 |
Ding, D | 1 |
Liu, H | 1 |
Zhang, M | 1 |
Zhao, YY | 1 |
Cheng, XL | 1 |
Cui, JH | 1 |
Yan, XR | 1 |
Wei, F | 1 |
Bai, X | 1 |
Lin, RC | 1 |
Chan, YL | 1 |
Ng, HK | 1 |
Leung, CB | 1 |
Yeung, DK | 1 |
Seccia, TM | 1 |
Rossi, GP | 1 |
Perna, AF | 2 |
Ingrosso, D | 2 |
Satta, E | 1 |
Lombardi, C | 1 |
Galletti, P | 1 |
D'Aniello, A | 2 |
De Santo, NG | 2 |
Testa, A | 1 |
Spoto, B | 1 |
Tripepi, G | 1 |
Mallamaci, F | 1 |
Malatino, L | 1 |
Fatuzzo, P | 1 |
Maas, R | 1 |
Boeger, R | 1 |
Zoccali, C | 1 |
Sasaki, O | 1 |
Hattori, N | 1 |
Nakahama, H | 1 |
Inoue, N | 1 |
Nakamura, S | 1 |
Inenaga, T | 1 |
Kohno, S | 1 |
Sawada, T | 1 |
Kawano, Y | 1 |
Geissler, A | 1 |
Fründ, R | 1 |
Kohler, S | 1 |
Eichhorn, HM | 1 |
Krämer, BK | 1 |
Feuerbach, S | 1 |
Lowenson, JD | 1 |
Clarke, S | 1 |
Persu, A | 1 |
Stoenoiu, MS | 1 |
Messiaen, T | 1 |
Davila, S | 1 |
Robino, C | 1 |
El-Khattabi, O | 1 |
Mourad, M | 1 |
Horie, S | 1 |
Feron, O | 1 |
Balligand, JL | 1 |
Wattiez, R | 1 |
Pirson, Y | 1 |
Chauveau, D | 1 |
Lens, XM | 1 |
Devuyst, O | 1 |
Menon, DK | 1 |
Sandford, RN | 1 |
Cassidy, MJ | 1 |
Bell, JD | 1 |
Baudouin, CJ | 1 |
Sargentoni, J | 1 |
Valovicová, E | 1 |
Spustová, V | 1 |
Dzúrik, R | 1 |
Cernácek, P | 1 |
Czerniak, Z | 2 |
Burzyński, S | 1 |
Young, GA | 1 |
Parsons, FM | 1 |
17 other studies available for aspartic acid and Kidney Failure, Chronic
Article | Year |
---|---|
Application of
Topics: Adult; Aspartic Acid; Choline; Creatine; Depression; Female; Frontal Lobe; Humans; Kidney Failure, C | 2020 |
Association between abnormal thalamic metabolites and sleep disturbance in patients with end-stage renal disease.
Topics: Adult; Aspartic Acid; Creatine; Female; Humans; Kidney Failure, Chronic; Magnetic Resonance Spectros | 2018 |
Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm.
Topics: Adenine; Animals; Aspartic Acid; Cholestenones; Chromatography, High Pressure Liquid; Creatinine; Do | 2012 |
(31)phosphorous and single voxel proton MR spectroscopy and diffusion-weighted imaging in a case of star fruit poisoning.
Topics: Aspartic Acid; Brain; Brain Chemistry; Diffusion Magnetic Resonance Imaging; Fruit; Humans; Kidney F | 2002 |
Endothelial nitric oxide synthase gene polymorphisms and renal survival.
Topics: Amino Acid Substitution; Aspartic Acid; Genetic Predisposition to Disease; Glutamic Acid; Humans; Ki | 2003 |
Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.
Topics: Asparagine; Aspartic Acid; Biomarkers; Blood Chemical Analysis; Blood Proteins; Diazepam; Female; Hu | 2004 |
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
Topics: Adult; Aged; Amino Acid Substitution; Analysis of Variance; Arginine; Aspartic Acid; Cardiovascular | 2005 |
Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Cerebral Cortex; Choline; Creatine; Female; Glutamic | 2006 |
Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glycine; Humans; Inositol; Kidney Failure, C | 1995 |
D-aspartate content of erythrocyte membrane proteins is decreased in uremia: implications for the repair of damaged proteins.
Topics: Adult; Aged; Aspartic Acid; Chromatography, High Pressure Liquid; Erythrocyte Aging; Erythrocyte Mem | 1997 |
Modifier effect of ENOS in autosomal dominant polycystic kidney disease.
Topics: Age of Onset; Aspartic Acid; Belgium; Female; France; Glutamic Acid; Humans; Kidney Failure, Chronic | 2002 |
Proton magnetic resonance spectroscopy in chronic renal failure.
Topics: Adult; Aged; Aspartic Acid; Brain Chemistry; Choline; Female; Humans; Kidney Failure, Chronic; Magne | 1991 |
The utilization of glucose in the brain slices during uraemia.
Topics: Ammonia; Animals; Aspartic Acid; Blood Proteins; Brain; Cerebral Cortex; gamma-Aminobutyric Acid; Gl | 1974 |
N-substituted amino acids in serum of patients with chronic renal insufficiency.
Topics: Alanine; Amino Acids; Aspartic Acid; Cystine; Glutamates; Glycine; Humans; Kidney Failure, Chronic; | 1970 |
[Free, N-substituted and peptide amino acids in urine of patients with chronic renal insufficiency].
Topics: Adult; Aged; Amino Acid Metabolism, Inborn Errors; Amino Acids; Aspartic Acid; Female; Glycine; Huma | 1970 |
Bound amino acids in serum of patients with chronic renal insufficiency.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Aspartic Acid; Chromatography, Paper; Female; Glomer | 1969 |
The effect of peritoneal dialysis upon the amino acids and other nitrogenous compounds in the blood and dialysates from patients with renal failure.
Topics: Adult; Amino Acids; Aspartic Acid; Butyrates; Creatinine; Diet Therapy; Female; Glutamates; Glycine; | 1969 |